eMedicine Specialties > General Surgery > Colorectal

Rectovaginal Fistula: Treatment

Author: Dana Taylor, MD, FACS, Assistant Professor of Surgery, Graduate School of Medicine, University of Tennessee; Consulting Surgeon, University General Surgeons, PC
Coauthor(s): Jan Rakinic, MD, Chief, Section of Colorectal Surgery, Southern Illinois University; Program Director, SIU Residency in Colorectal Surgery
Contributor Information and Disclosures

Updated: Feb 11, 2009

Treatment

Medical Therapy

Use local care, drainage of abscesses, and directed antibiotic therapy to treat acute rectovaginal fistulas (RVFs) of traumatic origin (including those caused by obstetric2,3 and operative trauma), RVFs complicated by secondary infection, and fistulas of infectious origin. Allow tissues to heal for 6-12 weeks. Dietary modification and supplemental fiber can greatly diminish symptoms during this period. Many fistulas resulting from obstetric or operative trauma heal completely, requiring no further therapy. When the fistula persists after this period of treatment and the tissues become uninflamed and supple, repair may be considered.

Perform a biopsy on any area suggestive of neoplasm. Treat neoplasms as appropriate. In this setting, very symptomatic fistulas may prompt the physician and patient to consider a diverting colostomy for patient comfort. Otherwise, fecal diversion is rarely used with RVFs.1

If the evaluation is consistent with the diagnosis of IBD, institute appropriate medical therapy. Repair of an RVF can be performed while the patient is on steroids, with the understanding that the risk of failure is increased. Even after initial failed repair attempts, some patients with Crohn's disease can maintain RVF repair while on antimetabolites, such as 6-mercaptopurine or azathioprine (Imuran). Clinical use of infliximab (Remicade)7 suggests that few fistulas heal completely, but most patients are dramatically improved symptomatically. Predictors of failure requiring fecal diversion have been identified and include significant colonic involvement and the presence of anal stricture.1 The development of carcinoma has been described in Crohn fistulas.8

RVFs originating from radiation therapy are very difficult to treat surgically,4 and medical therapy is often initially recommended in this setting. Diet and fiber are the mainstays of therapy.

Surgical Therapy

See Intraoperative Details.

Preoperative Details

Complete mechanical bowel preparation is essential for the transabdominal repair of rectovaginal fistula (RVF) and is also recommended for local repairs. The practice of including poorly absorbed oral antibiotics in the bowel preparation is under scrutiny. New data suggest that intravenous antibiotics administered in a manner that provides appropriate tissue levels at the beginning of the operative procedure are sufficient for prophylaxis. The author recommends that prophylactic intravenous antibiotics be administered preoperatively for all patients undergoing RVF repairs, transabdominal or local.

Although diverting colostomy was used in the past, the overwhelming majority of RVFs are now repaired without this procedure being performed beforehand.

Cleanse the vaginal lumen with an antiseptic solution, such as Betadine. Insert a catheter into the urinary bladder.

If a transabdominal procedure is planned, perform standard preoperative cardiopulmonary evaluation as appropriate. Prophylaxis against venous thromboembolism is essential and may include the use of fractionated or unfractionated heparin, as well as the employment of sequential compression devices. If the pelvis has been irradiated or previously operated upon, the use of ureteral catheters may aid in dissection. A laparoscopic approach has been described.9

Intraoperative Details

Local repair methods

  • Transanal advancement flap repair10 - The best results have been reported with this type of repair. General, regional, or local anesthesia may be used. The patient is placed in the prone, flexed position with a hip roll in place; the buttocks are taped apart for exposure. The fistula is identified using the operating anoscope. A flap is outlined, extending at least 4 cm cephalad to the fistula, with the base of the flap twice the width of the apex to allow adequate blood supply to the flap tip. Local anesthetic with epinephrine is injected submucosally to facilitate raising the flap and to diminish bleeding.

    The flap, consisting of mucosa and submucosa, is raised; some surgeons include circular muscle as well. Meticulous hemostasis is imperative. The fistula tract is curetted gently. Circular muscle is closed over the fistula. The tip of the flap, which includes the fistula opening, is excised. The flap is sutured in place with simple interrupted, absorbable sutures, effectively closing the rectal opening of the fistula. The vaginal side of the fistula is left open for drainage. This approach separates the suture line from the fistula site and interposes healthy muscle between the rectal and vaginal walls. Proponents point out that the relatively high pressure within the rectum serves to buttress the repair, in contrast to a transvaginal repair, in which the intrarectal pressure is more prone to disrupt the repair. If indicated, sphincteroplasty can be performed concomitantly.11
  • Transvaginal inversion repair - The vaginal mucosa is circumferentially elevated, exposing the fistula. Two or 3 concentric pursestring sutures are used to invert the fistula into the rectal lumen. The vaginal mucosa is reapproximated. This approach is suitable only for small, low fistulas in otherwise healthy tissues with an intact perineal body. It is rarely performed today.
  • Bioprosthetic repair - Bioprosthetic interposition graft is placed by making a transverse incision over the midportion of the perineal body with dissection through the subcutaneous tissue. The fistula tract is transected. The dissection is continued 2 cm proximal to the transected fistula tract and laterally. The fistula openings are closed with 3/0 interrupted, absorbable sutures. The graft needs an overlap of 2 cm on all sides of the rectal and vaginal mucosal closures. A bioprosthetic plug is placed through the rectal opening and out the vaginal opening. The excess plug is trimmed and secured on the rectal side with 2/0 absorbable suture.
  • Conversion to complete perineal laceration with layer closure10 - The fistulous tract is laid open in the midline, essentially creating a cloaca. Closure in layers follows, identical to the classic obstetric repair of a fourth-degree perineal laceration. This method is described in the gynecologic literature; it is rarely employed by colorectal surgeons because of concerns of juxtaposed suture lines.
  • Simple fistulotomy - This procedure works well for true anovaginal fistulas, in which no sphincter is involved in the tract. If the technique is used to treat an RVF, however, partial or total fecal incontinence results.

Transabdominal approaches

Transabdominal approaches are generally used for high RVFs when the fistula originates from a neoplasm, from radiation, or, occasionally, from IBD. They are also used if concomitant disease (eg, diverticulitis) warrants an abdominal approach.

  • Fistula division and closure without bowel resection - This is the simplest abdominal approach. The rectovaginal septum is dissected, the fistula is divided, and the rectum and vagina are closed primarily without bowel resection. Interposition of healthy tissue, such as omentum, may be used to buttress the repair and separate the suture lines. Good results have been reported when the fistula is not large and the tissues available for closure are healthy.
  • Bowel resection - When tissues are abnormal because of irradiation, inflammation, or neoplasm, the repair is doomed to failure unless the abnormal tissues are resected. Preserve functional anal sphincters whenever possible by use of a low anterior resection, a coloanal anastomosis technique, or a pull-through; the last alternative has the poorest results with respect to continence. Rarely, abdominoperineal resection may be necessary for symptom control in the setting of radiation damage or neoplasm. An alternative, particularly in cases of poor operative risks or with patients whose survival is limited, is simple fecal diversion with a loop ileostomy or colostomy.
  • Ancillary procedures - A host of supplementary procedures have been described to augment bowel resection in the difficult pelvis. These include local flaps, such as the bulbocavernosus flap, and a variety of muscle, fascial, and musculocutaneous flaps for repair of large pelvic defects. A variety of graft procedures also have been described.12 All of these procedures have the goal of interposing healthy tissue between vaginal and rectal repairs. These are well described in the plastic surgery literature.

Postoperative Details

Local repairs

Pay attention to the patient's bowel habits. Constipation or diarrhea can disrupt a repair. The goal is a soft, formed, deformable stool. The patient is carefully counseled regarding diet, copious fluid intake, and the use of stool softeners. The use of bulking agents immediately after repair is at the discretion of the surgeon and is a matter of individual preference rather than of scientifically proven practice. The use of oral antibiotics also varies. The author prefers that patients use an oral broad-spectrum antibiotic for 3-5 days postoperatively, take 1 tablespoon of mineral oil orally twice daily for 2 weeks postoperatively, and avoid bulking agents for 2 weeks postoperatively. The patients need to refrain from sexual activity or any physical activity more strenuous than a slow walk for 3 weeks.

Abdominal repairs

Postoperative care is identical to the care administered to all patients who have undergone major laparotomy with bowel resection and anastomosis. Postoperative gastric decompression is performed selectively, expecting that 15-20% of patients require cessation of oral intake or gastric decompression for symptomatic postoperative ileus. Most patients can be offered sips of clear liquids on the first postoperative day. Early ambulation is beneficial in many ways. Continue perioperative prophylaxis for thromboembolic events until the patient is ambulating well.

Follow-up

Patients are seen 2 weeks after discharge for evaluation of wounds and bowel habits. In the absence of recurrent fistula symptoms or other specific indications, no follow-up investigation, aside from physical examination, is required. Specific signs and symptoms are investigated appropriately. For example, fever, diarrhea, and low abdominal pain indicating an abscess are evaluated by a CT scan of the abdomen and pelvis. In this setting, physical examination may be difficult because of patient discomfort.

Complications

Complications of local repairs

Bleeding is rarely encountered postoperatively, probably because of careful intraoperative hemostasis. If bleeding occurs beneath the flap, fistula recurrence is common. Infection is a feared complication, because it almost invariably results in a failed repair. However, good data on the incidence of infection after local repair are few. Of course, repairs may fail in the absence of infection as well (see Outcome and Prognosis). Rarely, postoperative pain precipitates urinary retention.

Complications of transabdominal repairs

These may include the usual complications of any laparotomy with bowel resection, including fistula recurrence. The most common complications are bleeding and wound infection, each with an incidence of less than 2-5% in reasonable-risk candidates. Pelvic abscess occurs in 5-7% of patients. Data from the United States and Europe suggest that anastomotic leaks occur more often than is clinically recognized. However, because intervention is indicated only in clinically evident leaks, routine postoperative anastomotic evaluation is not warranted.

More on Rectovaginal Fistula

Overview: Rectovaginal Fistula
Workup: Rectovaginal Fistula
Treatment: Rectovaginal Fistula
Follow-up: Rectovaginal Fistula
References
Further Reading

References

  1. Galandiuk S, Kimberling J, Al-Mishlab TG, et al. Perianal Crohn disease: predictors of need for permanent diversion. Ann Surg. May 2005;241(5):796-801; discussion 801-2. [Medline][Full Text].

  2. Bangser M. Obstetric fistula and stigma. Lancet. Feb 11 2006;367(9509):535-6. [Medline].

  3. Browning A, Menber B. Women with obstetric fistula in Ethiopia: a 6-month follow up after surgical treatment. BJOG. Nov 2008;115(12):1564-9. [Medline].

  4. Bricker EM, Johnston WD. Repair of postirradiation rectovaginal fistula and stricture. Surg Gynecol Obstet. Apr 1979;148(4):499-506. [Medline].

  5. Cohen JL, Stricker JW, Schoetz DJ, et al. Rectovaginal fistula in Crohn''s disease. Dis Colon Rectum. Oct 1989;32(10):825-8. [Medline].

  6. Shobeiri SA, Quiroz L, Nihira M. Rectovaginal fistulography: a technique for the identification of recurrent elusive fistulas. Int Urogynecol J Pelvic Floor Dysfunct. Jan 22 2009;[Medline].

  7. Gonzalez-Lama Y, Abreu L, Vera MI, et al. Long-term oral tacrolimus therapy in refractory to infliximab fistulizing Crohn's disease: a pilot study. Inflamm Bowel Dis. Jan 2005;11(1):8-15. [Medline].

  8. Laurent S, Barbeaux A, Detroz B, et al. Development of adenocarcinoma in chronic fistula in Crohn's disease. Acta Gastroenterol Belg. Jan-Mar 2005;68(1):98-100. [Medline].

  9. Kumaran SS, Palanivelu C, Kavalakat AJ, et al. Laparoscopic repair of high rectovaginal fistula: is it technically feasible?. BMC Surg. 2005;5:20. [Medline][Full Text].

  10. Casadesus D, Villasana L, Sanchez IM, et al. Treatment of rectovaginal fistula: a 5-year review. Aust N Z J Obstet Gynaecol. Feb 2006;46(1):49-51. [Medline].

  11. Khanduja KS, Yamashita HJ, Wise WE Jr. Delayed repair of obstetric injuries of the anorectum and vagina. A stratified surgical approach. Dis Colon Rectum. Apr 1994;37(4):344-9. [Medline].

  12. Jasonni VM, La Marca A, Manenti A. Rectovaginal fistula repair using fascia graft of autologous abdominal muscles. Int J Gynaecol Obstet. Jan 2006;92(1):85-6. [Medline].

  13. Ellis CN. Outcomes after repair of rectovaginal fistulas using bioprosthetics. Dis Colon Rectum. Jul 2008;51(7):1084-8. [Medline].

  14. Ulrich D, Roos J, Jakse G, et al. Gracilis muscle interposition for the treatment of recto-urethral and rectovaginal fistulas: a retrospective analysis of 35 cases. J Plast Reconstr Aesthet Surg. Jan 20 2009;[Medline].

  15. Loffler T, Welsch T, Muhl S, et al. Long-term success rate after surgical treatment of anorectal and rectovaginal fistulas in Crohn's disease. Int J Colorectal Dis. Jan 27 2009;[Medline].

  16. Burke C. Rectovaginal fistulas. Clin J Oncol Nurs. Jun 2005;9(3):295-7. [Medline].

  17. Fry RD, Kodner IJ. Rectovaginal fistula. Surg Annu. 1995;27:113-31. [Medline].

  18. Hilger WS, Cornella JL. Rectovaginal fistula after posterior intravaginal slingplasty and polypropylene mesh augmented rectocele repair. Int Urogynecol J Pelvic Floor Dysfunct. Jan 2006;17(1):89-92. [Medline].

  19. Husain A, Johnson K, Glowacki CA, et al. Surgical management of complex obstetric fistula in Eritrea. J Womens Health (Larchmt). Nov 2005;14(9):839-44. [Medline].

  20. MacRae HM, McLeod RS, Cohen Z. Treatment of rectovaginal fistulas that has failed previous repair attempts. Dis Colon Rectum. Sep 1995;38(9):921-5. [Medline].

  21. Miklos JR, Kohli N. Rectovaginal fistula repair utilizing a cadaveric dermal allograft. Int Urogynecol J Pelvic Floor Dysfunct. 1999;10(6):405-6. [Medline].

  22. Moore RD, Miklos JR, Kohli N. Rectovaginal fistula repair using a porcine dermal graft. Obstet Gynecol. Nov 2004;104(5 Pt 2):1165-7. [Medline].

  23. Nowacki MP. Ten years of experience with Parks' coloanal sleeve anastomosis for the treatment of post-irradiation rectovaginal fistula. Eur J Surg Oncol. Dec 1991;17(6):563-6. [Medline].

  24. Steichen FM, Barber HK, Loubeau JM, et al. Bricker-Johnston sigmoid colon graft for repair of postradiation rectovaginal fistula and stricture performed with mechanical sutures. Dis Colon Rectum. Jun 1992;35(6):599-603. [Medline].

  25. Tsang CB, Madoff RD, Wong WD. Anal sphincter integrity and function influences outcome in rectovaginal fistula repair. Dis Colon Rectum. Sep 1998;41(9):1141-6. [Medline].

  26. Tsang CB, Rothenberger DA. Rectovaginal fistulas. Therapeutic options. Surg Clin North Am. Feb 1997;77(1):95-114. [Medline].

Keywords

rectovaginal fistula, fistula, Crohn's disease, IBD, fistulas, fistula surgery, inflammatory bowel disease, fistula repair, Crohn disease, ulcerative colitis, advancement flap, obstetric fistula, anovaginal fistulas, obstetric injury, radiation injury, operative trauma, perineal lacerations, forceful coitus, perirectal abscess, diverticulitis, tuberculosis, lymphogranuloma venereum, Bartholin gland abscess, vaginitis, cystitis, sigmoid-vaginal cuff fistulas, proctosigmoidoscopy, sigmoidoscopy, colonoscopy, colostomy

Contributor Information and Disclosures

Author

Dana Taylor, MD, FACS, Assistant Professor of Surgery, Graduate School of Medicine, University of Tennessee; Consulting Surgeon, University General Surgeons, PC
Dana Taylor, MD, FACS is a member of the following medical societies: American College of Chest Physicians, American College of Surgeons, American Medical Association, Eastern Association for the Surgery of Trauma, and Southeastern Surgical Congress
Disclosure: Nothing to disclose.

Coauthor(s)

Jan Rakinic, MD, Chief, Section of Colorectal Surgery, Southern Illinois University; Program Director, SIU Residency in Colorectal Surgery
Jan Rakinic, MD is a member of the following medical societies: American College of Surgeons, American Medical Association, American Medical Women's Association, American Society of Colon and Rectal Surgeons, and Illinois State Medical Society
Disclosure: Nothing to disclose.

Medical Editor

Lewis J Kaplan, MD, FACS, FCCM, FCCP, Director, SICU and Surgical Critical Care Fellowship, Associate Professor, Department of Surgery, Section of Trauma, Surgical Critical Care, and Surgical Emergencies, Yale University School of Medicine
Lewis J Kaplan, MD, FACS, FCCM, FCCP is a member of the following medical societies: American Association for the Surgery of Trauma, American College of Surgeons, Association for Academic Surgery, Association for Surgical Education, Connecticut State Medical Society, Eastern Association for the Surgery of Trauma, International Trauma Anesthesia and Critical Care Society, Society for the Advancement of Blood Management, Society of Critical Care Medicine, and Surgical Infection Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

David L Morris, MD, PhD, Professor, Department of Surgery, St George Hospital, University of New South Wales, Australia
Disclosure: RFA Medical None Director; MRC Biotec None Director

CME Editor

Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy
Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences
Disclosure: Nothing to disclose.

Chief Editor

John Geibel, MD, DSc, MA, Vice Chairman, Professor, Department of Surgery, Section of Gastrointestinal Medicine and Department of Cellular and Molecular Physiology, Yale University School of Medicine; Director of Surgical Research, Department of Surgery, Yale-New Haven Hospital
John Geibel, MD, DSc, MA is a member of the following medical societies: American Gastroenterological Association, American Physiological Society, American Society of Nephrology, Association for Academic Surgery, International Society of Nephrology, New York Academy of Sciences, and Society for Surgery of the Alimentary Tract
Disclosure: AMGEN Royalty Other

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.